3 QUESTIONS. 3 HINTS. 3 ANSWERS.
September 20, 2016
- How has technology likely changed the requirement to “please rise”?
Hint:
Answer: particular courtrooms have likely done away with the requirement to rise. Electronic courtroom services have emerged in response to geographical and other issues associated with litigation. One such company, Opus 2 International, recently developed a fully integrated, seamless and efficient, courtroom in Miami, with one following in New York. Now one can presumably show up to court in…pajamas. Read more here.
2. Though we haven’t seen stain-resistant jeans, in what area have we seen a rise in other resistant genes?
Hint:
Answer: bacteria, through its genetic make-up, resistant to an antibiotic of last resort, Colostin, has been discovered for the fourth time in the U.S. There is worry that the resistance gene could spread to other bacteria leading to an array of infections that do not respond to treatment. The fourth case is presumed to have become ill from something ingested while vacationing in the Caribbean. Read the details here.
3. Hot in the news: should the FDA bring the hammer down on these types of services?
Hint:
Answer: stem cell therapy is the latest controversy at the FDA. There are a few hundred clinics that are marketing and offering services to help cure several ailments, including some that target a vulnerable class of individuals. The FDA has approved a limited set of stem cell treatments and is trying to reign in the others. Lack of alleged sufficient and reliable support for success claims has led the FDA to look at such practices with more scrutiny, blocking access in some cases. This, despite push-back by industry that FDA approval is not required in certain instances due to the nature of the therapeutic applications. For patients looking for relief, the FDA’s vigilance is uncalled for. Others prefer more oversight, particularly when it affects a segment of vulnerable society. Read the specifics here.